Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
Cunningham, E. B., et al.
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.
Robaeys, G., et al.
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse
Lamoury, F. M. J., et al.
Früherkennung und Umgang mit risikoreichem Alkoholkonsum
Tibor Rasovszky
Internists' career choice towards primary care: a cross-sectional survey.
Scherz, N., et al.
Versorgungslücken bei Hepatitis-C-infzierten Drogenkonsumierenden.
Philip Bruggmann
Themen
Faktenblätter
- Addiction,
- Ars Medici,
- BMC Cancer,
- BMC Family Practice,
- BMC Infectious Diseases,
- BMC Public Health,
- European Addiction Research,
- Infectious Diseases and Therapy,
- International Journal of Drug Policy,
- Journal of Clinical Virology,
- Journal of Viral Hepatitis,
- Liver International,
- Medizin Forum,
- Open Forum Infectious Diseases,
- Praxis,
- Primary & Hospital Care,
- Sucht,
- Suchtmagazin,
- Swiss Medical Forum,
- The Journal of Clinical Pharmacology,
- The Lancet Gastroenterology and Hepatology
